Latest Breaking News On - Independent safety committee - Page 1 : comparemela.com

FIVE at FIVE AU: ASX dips dragged down by BHP acquisition news; keep an eye on healthcare sector

FIVE at FIVE AU: ASX dips dragged down by BHP acquisition news; keep an eye on healthcare sector
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Fraser rangeWestern australiaNew south walesUnited statesAtlantic ewoyaaKeith mullerDale gillhamElisha newellHealius ltdTradegate exchangeGlobe metals mining ltdLendlease group ltdRecce pharmaceuticalsFrankfurt stock exchangeBellevue gold ltdSafety committee

Recce Pharmaceuticals R327 approved for increase to 4,000mg IV over a fast infusion of 30 minutes

Recce Pharmaceuticals R327 approved for increase to 4,000mg IV over a fast infusion of 30 minutes
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

James grahamRecce pharmaceuticals ltdDrug administrationRecce pharmaceuticalsGlobal new antibiotics in development pipelineSafety committeeIndependent safety committeeGood manufacturing practicesQualified infectious disease productGenerating antibiotic initiatives nowFast trackPew charitable trustsGlobal new antibioticsDevelopment pipeline

Recce Pharmaceuticals Announces Expansion of Phase I/II Trial of RECCE® 327 for the Treatment of Diabetic Foot Infections

Independent Safety Committee unanimously agrees that the Phase I/II trial is safe, well tolerated, and fit for expanded accessStudy achieving primary endpoints of safety, tolerability, and efficacy by resolving/curing bacterial infections in patients with diabetic foot ulcersRECCE® 327 dosed daily or every second day for 14 days is considered to be safe and well-toleratedAdditional clinical sites to be launched in Australia, and additional clinical trials will be launched internationally in diab

United statesNew south walesJames grahamAndrew geddesMichael fitzhughGuillaume van renterghemHugh dicksonRecce pharmaceuticals ltdSafety committeeSafety committee of liverpool hospitalLifesci communicationsRecce pharmaceuticalsIndependent safety committeePharmaceuticals ltdLiverpool hospitalProfessor hugh dickson

NRC Accepts PG&E s Application for Diablo Canyon Power Plant - The Santa Barbara Independent

NRC Accepts PG&E s Application for Diablo Canyon Power Plant - The Santa Barbara Independent
independent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independent.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoDiablo canyon power plantCalifornia senateCalifornia public utilities commissionDiablo independent safety committeeNuclear regulatory commissionFollowing diablo canyon power plantSenate billNorthern californiaReactor unitsGovernor newsomProposed decisionIndependent safety committeeSocal edisonSan diego gas

Recce Pharmaceuticals welcomes safety committee approval of faster infusion rate for RECCE® 327 in urosepsis clinical trial

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has been given the green light by an independent safety committee for the next cohort dosing of RECCE®.

James grahamSafety committeeRecce pharmaceuticalsSepsis campaignRecce pharmaceuticals ltdIndependent safety committeeQualified infectious disease productFast track designationPew charitable trusts global new antibiotics